Health In Tech, Inc. (NASDAQ:HIT – Get Free Report) Director Timothy Hayes sold 12,000 shares of the company’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $0.91, for a total value of $10,920.00. Following the completion of the sale, the director owned 120,780 shares of the company’s stock, valued at $109,909.80. This represents a 9.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Timothy Hayes also recently made the following trade(s):
- On Wednesday, September 9th, Timothy Hayes sold 5,730 shares of Health In Tech stock. The stock was sold at an average price of $0.93, for a total value of $5,328.90.
Health In Tech Trading Down 2.7%
Shares of HIT opened at $0.91 on Friday. The stock has a market cap of $59.36 million, a P/E ratio of -12.94 and a beta of 2.72. Health In Tech, Inc. has a 1 year low of $0.85 and a 1 year high of $4.02. The stock’s 50-day moving average price is $1.04 and its two-hundred day moving average price is $1.23.
Institutional Trading of Health In Tech
A number of large investors have recently bought and sold shares of HIT. Cubist Systematic Strategies LLC bought a new position in Health In Tech in the first quarter valued at approximately $41,000. Jane Street Group LLC acquired a new position in shares of Health In Tech in the first quarter valued at approximately $48,000. Squarepoint Ops LLC bought a new stake in shares of Health In Tech during the third quarter worth $46,000. Two Sigma Investments LP bought a new stake in shares of Health In Tech during the third quarter worth $386,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Health In Tech during the third quarter worth $45,000.
Wall Street Analysts Forecast Growth
Several analysts recently commented on HIT shares. Maxim Group dropped their price objective on Health In Tech from $4.00 to $3.00 and set a “buy” rating on the stock in a research note on Friday, August 14th. Weiss Ratings reissued a “sell (d)” rating on shares of Health In Tech in a research note on Tuesday, June 30th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $3.50.
Read Our Latest Analysis on Health In Tech
Health In Tech Company Profile
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
See Also
- Five stocks we like better than Health In Tech
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
